Nature Communications (May 2024)

Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase

  • Stéphanie Bibert,
  • Mathieu Quinodoz,
  • Sylvain Perriot,
  • Fanny S. Krebs,
  • Maxime Jan,
  • Rita C. Malta,
  • Emilie Collinet,
  • Mathieu Canales,
  • Amandine Mathias,
  • Nicole Faignart,
  • Eliane Roulet-Perez,
  • Pascal Meylan,
  • René Brouillet,
  • Onya Opota,
  • Leyder Lozano-Calderon,
  • Florence Fellmann,
  • Nicolas Guex,
  • Vincent Zoete,
  • Sandra Asner,
  • Carlo Rivolta,
  • Renaud Du Pasquier,
  • Pierre-Yves Bochud

DOI
https://doi.org/10.1038/s41467-024-48287-0
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Encephalitis is a rare and potentially fatal manifestation of herpes simplex type 1 infection. Following genome-wide genetic analyses, we identified a previously uncharacterized and very rare heterozygous variant in the E3 ubiquitin ligase WWP2, in a 14-month-old girl with herpes simplex encephalitis. The p.R841H variant (NM_007014.4:c.2522G > A) impaired TLR3 mediated signaling in inducible pluripotent stem cells-derived neural precursor cells and neurons; cells bearing this mutation were also more susceptible to HSV-1 infection compared to control cells. The p.R841H variant increased TRIF ubiquitination in vitro. Antiviral immunity was rescued following the correction of p.R841H by CRISPR-Cas9 technology. Moreover, the introduction of p.R841H in wild type cells reduced such immunity, suggesting that this mutation is linked to the observed phenotypes.